Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MUNIN PHARMA AS
AS
Active
Org 991311955
Kongleveien 21, 8027 Bodø
Intermediation service activities for specialised retail sale · NACE 4792
Est. 2007
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
+59% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -2K
+58% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -2K
+59%
Net profit
NOK -2K
+58%
Total assets
NOK 63K
+5%
Equity
NOK 63K
+5%
Employees
0
—
Company information
Legal name
MUNIN PHARMA AS
Org number
991311955
Legal form
Aksjeselskap
NACE code
4792 · Intermediation service activities for specialised retail sale
Founded
21. juli 2007
Share capital
NOK 60 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av kosttilskudd og helseprodukter.
Contact
Address
Kongleveien 21, 8027 Bodø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Intermediation service activities for specialised retail sale
Companies in Bodø
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
36
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
7
−2
−2
−5
−2
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
7
−2
−2
−5
−2
Net financials
−2
−2
0
0
−0
Profit before tax
5
−4
−2
−5
−2
Tax
−0
−0
−7
−0
−0
Net profit
4
−4
5
−5
−2
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
78
73
65
60
63
Equity
60
60
65
60
63
Long-term debt
13
10
0
0
0
Short-term debt
4
3
0
0
0
Total debt
18
13
0
0
0
Financial ratios
5-year trend
EBITDA margin
-214800.0%
This company
15.8%
Market median
-1359594% vs market
2020
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2020
2024
Return on equity
-3.5%
This company
18.4%
Market median
-119% vs market
2020
2024
Net profit margin
-220600.0%
This company
8.1%
Market median
-2723557% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
RS
Robert Solberg
Chairman
2018
ST
Simen Trondsen
Board of Directors
2018
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MUNIN PHARMA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Robert Solberg
Chairman
0 companies
Simen Trondsen
Board of Directors
0 companies